{
  "DB14596": {
    "drugbank_id": "DB14596",
    "name": "Loteprednol etabonate",
    "description": "Loteprednol Etabonate (LE) is a topical corticoid anti-inflammatory. It is used in ophthalmic solution for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal spray, it can be used for the treatment and management of seasonal allergic rhinitis.\n\n\n\nMost prescription LE products, however, tend to be indicated for the treatment of post-operative inflammation and pain following ocular surgery [FDA Label]. A number of such new formulations that have been approved include Kala Pharmaceutical's Inveltys - the first twice-daily (BID) ocular corticosteroid approved for this indication, designed specifically to enhance patient compliance and simplified dosing compared to all other similar ocular steroids that are dosed four times daily [L4545].\n\n\n\nMoreover, LE was purposefully engineered to be a 'soft drug', one that is designed to be active locally at the site of administration and then rapidly metabolized to inactive components after eliciting its actions at the desired location, thereby subsequently minimizing the chance for adverse effects [A38693].",
    "cas_number": "82034-46-6",
    "unii": "YEH1EZ96K6",
    "scientific_articles": [
      {
        "ref_id": "A1312",
        "pubmed_id": "18245274",
        "citation": "Pavesio CE, Decory HH: Treatment of ocular inflammatory conditions with loteprednol etabonate. Br J Ophthalmol. 2008 Apr;92(4):455-9. doi: 10.1136/bjo.2007.132621. Epub 2008 Feb 1."
      },
      {
        "ref_id": "A38681",
        "pubmed_id": "28017774",
        "citation": "Samir A, Bodor N, Imai T: Identification of esterase involved in the metabolism of two corticosteroid soft drugs. Biochem Pharmacol. 2017 Mar 1;127:82-89. doi: 10.1016/j.bcp.2016.12.010. Epub 2016 Dec 22."
      },
      {
        "ref_id": "A38682",
        "pubmed_id": "1491342",
        "citation": "Hochhaus G, Chen LS, Ratka A, Druzgala P, Howes J, Bodor N, Derendorf H: Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs. J Pharm Sci. 1992 Dec;81(12):1210-5."
      },
      {
        "ref_id": "A38693",
        "pubmed_id": "1959381",
        "citation": "Druzgala P, Wu WM, Bodor N: Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Curr Eye Res. 1991 Oct;10(10):933-7."
      }
    ],
    "general_references": {
      "links": [
        {
          "ref_id": "L4539",
          "title": "Electronic Medicines Compendium: Loteprednol etabonate Monograph",
          "url": "https://www.medicines.org.uk/emc/product/6212",
          "category": null
        },
        {
          "ref_id": "L4545",
          "title": "Inveltys FDA Approval Press Release",
          "url": "https://www.drugs.com/newdrugs/fda-approves-inveltys-loteprednol-etabonate-post-operative-inflammation-pain-following-ocular-4808.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+August+24%2C+2018&utm_content=FDA+Approves+Inveltys+%28loteprednol+etabonate%29+for+Post-Operative+Inflammation+and+Pain+Following+Ocular+Surgery",
          "category": null
        },
        {
          "ref_id": "L19889",
          "title": "FDA Approved Drug Products: Eysuvis (loteprednol etabonate) ophthalmic suspension",
          "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210933s000lbl.pdf",
          "category": null
        },
        {
          "ref_id": "F1467",
          "title": "Australian Register of Therapeutic Goods: Loteprednol etabonate Product Information",
          "url": "//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/467/original/auspar-loteprednol-etabonate-140417-pi.docx?1536691506",
          "category": null
        }
      ]
    },
    "regulatory_links": [
      {
        "ref_id": "RxList",
        "title": "RxList",
        "url": "http://www.rxlist.com/cgi/generic2/lotemax.htm",
        "category": null
      },
      {
        "ref_id": "Drugs.com",
        "title": "Drugs.com",
        "url": "http://www.drugs.com/international/loteprednol.html",
        "category": null
      }
    ],
    "packagers": [
      "Alchymars SPA",
      "Bausch & Lomb Inc.",
      "Physicians Total Care Inc."
    ],
    "manufacturers": [
      "Bausch and lomb inc",
      "Pharmos corp"
    ],
    "external_identifiers": [
      {
        "resource": "Drugs Product Database (DPD)",
        "identifier": "20429"
      },
      {
        "resource": "ChEBI",
        "identifier": "31784"
      },
      {
        "resource": "PubChem Compound",
        "identifier": "9865442"
      },
      {
        "resource": "PubChem Substance",
        "identifier": "46504713"
      },
      {
        "resource": "KEGG Drug",
        "identifier": "D01689"
      },
      {
        "resource": "ChemSpider",
        "identifier": "392049"
      },
      {
        "resource": "PharmGKB",
        "identifier": "PA164764569"
      },
      {
        "resource": "Therapeutic Targets Database",
        "identifier": "DAP001045"
      },
      {
        "resource": "Wikipedia",
        "identifier": "Loteprednol"
      },
      {
        "resource": "ChEMBL",
        "identifier": "CHEMBL1200865"
      },
      {
        "resource": "ZINC",
        "identifier": "ZINC000003920673"
      }
    ],
    "raw_fields": {}
  },
  "DB01323": {
    "drugbank_id": "DB01323",
    "name": "St. John's Wort",
    "description": null,
    "cas_number": "84082-80-4",
    "unii": "UFH8805FKA",
    "scientific_articles": [
      {
        "ref_id": "A2388",
        "pubmed_id": "12153829",
        "citation": "Lecrubier Y, Clerc G, Didi R, Kieser M: Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry. 2002 Aug;159(8):1361-6."
      },
      {
        "ref_id": "A2389",
        "pubmed_id": "16423519",
        "citation": "Randlov C, Mehlsen J, Thomsen CF, Hedman C, von Fircks H, Winther K: The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study. Phytomedicine. 2006 Mar;13(4):215-21. Epub 2006 Jan 19."
      },
      {
        "ref_id": "A2390",
        "pubmed_id": "11939866",
        "citation": "Authors unspecified: Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002 Apr 10;287(14):1807-14."
      }
    ],
    "general_references": {
      "links": []
    },
    "regulatory_links": [
      {
        "ref_id": "Drugs.com",
        "title": "Drugs.com",
        "url": "http://www.drugs.com/cdi/st-john-s-wort.html",
        "category": null
      }
    ],
    "packagers": [
      "Guna Inc.",
      "Pekana Naturheilmittel GmbH",
      "Weleda Inc."
    ],
    "manufacturers": [],
    "external_identifiers": [
      {
        "resource": "Drugs Product Database (DPD)",
        "identifier": "294"
      },
      {
        "resource": "PubChem Substance",
        "identifier": "46507869"
      },
      {
        "resource": "PharmGKB",
        "identifier": "PA164924486"
      },
      {
        "resource": "Wikipedia",
        "identifier": "Hypericum_perforatum"
      },
      {
        "resource": "RxCUI",
        "identifier": "1310069"
      }
    ],
    "raw_fields": {}
  }
}